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Perspectives on GME Reform
Although an occasional federal or state legislator
will pose the question of why the public should fund the
training of physicians, explicit financial support of
graduate medical education (GME)1 seems to be a
standard budget item in the federal Medicare program
and in most state Medicaid programs. The amount and
allocation of the support are more doubtful, however.
Various proposals have come forth in the last decade,
some aimed at directing the funds to certain workforce
goals, some at diverting or dividing teaching hospitals’
direct pipeline to GME dollars (particularly for Medi-
care), and some at broadening the base of public
subsidization to the private sector.
One program, the Children’s Hospital Graduate
Medical Education (CHGME) program, established by
the Healthcare Research and Quality Act of 1999, relies
on discretionary funding, as do certain health profes-
sions education programs, such as advanced practice
nursing and family medicine, that are in Titles VII and
VIII of the Public Health Service Act. The CHGME
program funnels GME payments to approximately 60
freestanding children’s hospitals through the federal
authorization and appropriation process. Because the
Medicare and Medicaid entitlements in the Social
Security Act are ongoing, whereas authorizations and
appropriations are subject to renewal by Congress and
the president, the CHGME approach is unsettling to
Medicare GME recipients.
Medicare GME this year is expected to provide $3
billion in direct payments to teaching hospitals for the
salaries and fringe benefits of residents and supervisory
faculty, as well as overhead costs (generally called
“direct graduate medical education,” or DGME).2 The
program is expected to pay $5.2 billion in indirect
payments to teaching hospitals to recognize, according
to the Social Security Amendments of 1983, the higher
Medicare inpatient costs they incur as a result of being
teaching institutions. The payments, under the label of
“the indirect medical education (IME) factor,” are
adjustments to diagnosis-related group (DRG) rates
under the Medicare prospective payment system (PPS).
It is not known how many billions in toto the 45 Medic-
aid GME-paying states, plus the District of Columbia,
will pay this year; the amount for 1998 was estimated to
be between $2.3 billion and $2.4 billion.3 According to
the Association of American Medical Colleges
(AAMC), non-Medicaid state appropriations were
approximately $3.3 billion in 1998-1999.
In addition, some private insurers recognize GME
costs through higher payments to teaching hospitals than
to nonteaching hospitals for services provided their
members, although more stringent financial arrange-
ments between insurers and hospitals have threatened
such payments in recent years. It is important to keep in
mind that the greatest proportion of GME financing
comes from patient care revenues, not only from payers
that implicitly provide higher payments for that purpose
but also from faculty practice plan dollars that subsidize
clinicians, clinical departments, or medical schools.
According to an estimate presented in April 2001 by
Marilyn Biviano of the Bureau of Health Professions
(BHPr), Health Resources and Services Administration
(HRSA), Medicare provides 40 percent, Medicaid 10
percent, and BHPr 1 percent of GME financing, and “all
other” contributes 49 percent.4
Because GME payments are entrenched in law and
practice, changing their goals, recipients, and formu-
las—the foci of reform proposals—is one of the most
challenging aspects of health policy. Given the fact that
GME payments are commingled with other funds, not
only patient service but also clinical research dollars at
teaching hospitals, it is even daunting to track where the
funds go. For these reasons, most reformers have not
gotten very far. Some have questioned the proportion of
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specialists over generalists emerging from residency
programs and considered ways of changing the balance.
Some have made minor attempts to shift the locus of
training (and the dollar flows) from inpatient to ambula-
tory settings. And, some have looked at broadening the
base of support through establishment of an all-payer
fund to supplement public with explicit private dollars.
The proposal has lingered since 1994, when academic
medicine and the managed care industry, and others
(but not the American Medical Association) signed onto
an all-payer fund provision in the Clinton administra-
tion’s Health Security Act proposal.
For Medicare, the main GME reform proposals seem
to fall into the following categories: (a) tinkering with
the existing system, (b) scuttling the present system for
an approach that would combine DGME and IME into
a targeted program, (c) shifting DGME and IME funds
from entitlement to appropriated dollars, and (d)
establishing an all-payer system. Because each state has
its own Medicaid program, with only Alaska, Idaho,
Illinois, Montana, and South Dakota (along with Puerto
Rico) not reporting any funds to GME, the Medicaid
issues are more difficult to categorize. However,
because each state Medicaid program is a separate
entity—albeit in partnership with the federal govern-
ment, which sets mandatory and optional criteria and
provides matching funds—the states reflect diversity in
the Medicaid GME approaches they use. In some cases,
they also are willing to experiment with new GME
initiatives to try to achieve educational and workforce
goals. The more adventurous states include Michigan,
Minnesota, New York, Tennessee, Texas, and Utah.
This Forum session will explore federal and state
perspectives on GME reform. After underlining the basis
for explicit public financial support of GME, the meeting
will look at the impact on a state basis. Contributing to the
discussion will be an analysis of Medicare GME pay-
ments across various states, as well as a look at state
Medicaid and discretionary approaches and their rele-
vance to health workforce planning. The session will also
explore the role of individual hospital variations—the
characteristics or practices of individual hospitals that
result in different GME payment amounts. These are
expected to lead to discussion among presenters and
participants of various proposals for GME reform.
SOME JUSTIFICATIONS FOR
PUBLIC SUPPORT OF GME
The rationale for devoting Medicare and Medicaid
funds to GME goes back to the mid-1960s, when the
two programs were enacted. At the time that drafters
were devising the two programs, the federal govern-
ment was concerned about the number and distribution
of physicians in the United States and was promoting
policies to build the physician workforce.
Ratios of total physicians per 100,000 total population
varied little between 1950 and 1965. However, ratios
in subsequent years reflect substantial changes in
physician supply. In 1997, there were over 98.6%
more physicians per 100,000 total population than 37
years earlier—142 (1960) and 282 (1997). In absolute
counts, the total physician population grew by 190.5%
between 1960 and 1997, from 260,484 to 756,710,
while the total population increased by only 45.9%,
from approximately 183 million to over 267 million in
the same interim. These data indicate physician
growth at a rate over four times faster than that of the
total population.5
Moreover, the drafters of the Medicare enacting legisla-
tion relied on private insurance models that recognized
GME costs as a societal responsibility. The concept of
GME being a public good remains, although few policy
people question the adequacy of the supply of physicians.
Some, however, voice doubts about the geographic and
specialty distribution, as well as the proportion of interna-
tional medical graduates (IMGs) to U.S. graduates.
To underline the legitimacy of GME, academic
medicine cites this language in the House of Represen-
tatives and Senate reports that accompanied the Medi-
care legislation:
Educational activities enhance the quality of care in an
institution, and it is intended, until the community
undertakes to bear such education costs in some other
way, that a part of the net cost of such activities
(including stipends of trainees, as well as compensa-
tion of teachers and other costs) should be borne to an
appropriate extent by the hospital insurance program.6
That is, the Hospital Insurance (HI)—or Medicare Part
A—Trust Fund, financed by a payroll tax, should
underwrite a portion of such activities.
The Case for Teaching Hospitals
In a recent article published in Academic Medicine,
Ralph W. Muller, immediate past chair of the AAMC,
gave the AAMC’s rationale for public support of
teaching hospitals and medical schools:
 About half, overall, of teaching hospitals’ patients
have public insurance. In 1998, approximately 30
percent of patients treated by teaching hospitals
were Medicare beneficiaries and 20 percent were
Medicaid recipients.
 4 
 Teaching hospitals “provide services that are not
generally available in all hospitals.” They are the
“specialty centers” to which people go for advanced
specialized care. For example, in contrast to 6 percent
of all hospitals, 66 percent of teaching hospitals
performed organ transplants in 1998. Compared with
24 percent of all hospitals, 73 percent of teaching
hospitals gave trauma care. As opposed to 12 percent
of all hospitals, 65 percent had neonatal units.
 According to “mounting evidence,” teaching hospi-
tals “do better in providing higher quality care. An
analysis of care in ‘high-volume hospitals’ found that
patients referred have significantly better mortality
results than do those in low-volume hospitals for
several major procedures and diagnoses.”
 Teaching hospitals “not only provide specialty care
but also serve their communities’ need for primary
care.” The settings in which the care is provided
“are diverse, from hospital-based clinics to federally
qualified health centers (FQHCs) located in neigh-
borhoods that are underserved.”
 Teaching hospitals provide “complex care.” Patients
tend to “be seen by several doctors, who receive
consults from others, and attract the considerable
interest of a team of medical students, residents, and
fellows.” Medical centers are
organic entities that have grown over decades to
handle complicated tasks and complex missions..
The people who are skilled in handling the chal-
lenges of [medical] centers are not optimized as
economically efficient actors but instead are
organized—institutionally, culturally, and even
politically—to meet complicated situations within
a team of highly talented individuals.
 Teaching hospitals are social institutions. They may
be the largest employers in their communities, have
emergency rooms open 24 hours a day, and operate
social-service units that link patients to other institu-
tions in their communities.7
Challenges from Others
Others think public support of GME can be useful in
achieving certain health professions education and
health service goals. These include organizations (such
as the National Association of Community Health
Centers) that want to direct GME funds from teaching
hospitals to ambulatory facilities as well as organiza-
tions (such as the American Academy of Family Physi-
cians) that view GME funds as crucial in shaping the
health workforce.
Among their goals are governing the rate of growth in
the supply of physicians, providing incentives for a higher
proportion of generalists to specialists, increasing the
numbers of ethnic and racial minorities in the physician
workforce, and assuring safety-net providers. The Council
on Graduate Medical Education (COGME) included
these goals in a document—the “Fifteenth Report”—that
it issued on GME financing at the end of 2000.8
MEDICARE GME POLICY
Medicare GME payments “are linked to services
provided to Medicare beneficiaries,” COGME’s Fifteenth
Report states.9 That is, rather than recognizing medical
education costs per se, they address the link between
medical education and health care services provided to
patients covered by the Medicare program. As the major
public payer of GME costs, Medicare law defines the
program’s responsibility in terms of the following: (a)
Medicare DGME expenditures for the salaries and
benefits of medical residents, the faculty who supervise
them, and the personnel who handle the clerical work
concerning them, as well as for the allocated overhead
costs of the institutions that train them, and (b) the Medi-
care IME factor for patient care costs—not captured by
DGME—that are due to teaching. (While Medicare GME
obviously emphasizes the training of physicians, it is
important to note that some of the funds go to the educa-
tion of nurses. For example, teaching hospitals with
diploma nursing schools, which have declined over the
past two decades as organized nursing has pushed for
baccalaureate and even more advanced nurses, receive
some Medicare GME funds for nurse training.)
Changes in DGME over Time
For the first 20 years of the Medicare program,
Medicare picked up “allowable” teaching hospital costs.
However, a series of omnibus reconciliation measures
limited reimbursement of the costs:
 The Consolidated Omnibus Budget Reconciliation
Act of 1985 (COBRA, actually enacted in 1986)
limited the costs to a capitated per-resident amount
(figured on a hospital-by-hospital basis) and to a
defined number of residency years for full Medicare
reimbursement.
 The Balanced Budget Act of 1997 (BBA) capped
the number of residents who could be counted. The
BBA also added a provision permitting the Medi-
care program to pay certain ambulatory sites for
DGME costs. These sites include Medicare-partici-
pating FQHCs, rural health clinics, Medicare+Choice
5 
organizations, and other entities as designated by the
Medicare program. The conference report that
accompanied the measure expressed concern over
Prospective Payment Assessment Commission and
Physician Payment Review Commission studies10
showing wide variation in per-resident amounts
from hospital to hospital.
 The Balanced Budget Refinement Act of 1999
(BBRA) created both a minimum payment level and
a maximum payment level for hospital per-resident
amounts.
 The Benefits Improvement and Protection Act of
2000 (BIPA) raised the minimum level but did not
change the maximum level.
Variations in GME payments in selected states are
featured in a paper—commissioned by the California
HealthCare Foundation—by Thomas R. Oliver, Ph.D.,
and Atul Grover, M.D., of Johns Hopkins University, as
well as Philip R. Lee, M.D., of the University of Cali-
fornia at San Francisco.11 The paper examines varia-
tions in Medicare GME payments that occur in states
that receive the highest amount of DGME and IME
support. It reports the variations, tracks their growth
since the implementation of PPS, and seeks to give
reasons for them. For example, the paper includes a
table that presents Medicare GME payments for the top
five teaching hospitals in six states (see Table 1).
Because both the BBRA and BIPA contained
provisions—by establishing floors and ceilings—to
narrow the variation in DGME payments, the profiles of
hospitals and states may look somewhat different in the
future, according to Michael Hash of Health Policy
Alternatives.12 It is difficult to estimate exactly how the
distribution of payments will change. Although DGME
is smaller than IME in terms of GME payments, it
arguably reflects differences in payment that are the
result of organizational decisions and circumstances
that determine how to finance the costs of residency
programs. Since residency stipends do not vary widely
across the country, faculty costs and overhead expenses
have generally been found to account for most of the
variation. Moreover, the significance of faculty practice
plans, volunteer faculty, fully salaried faculty, and
specific overhead costs needs to be determined.
Because Medicare PPS was designed to be a competi-
tive “winners and losers” program, examining state
variations is bound to be controversial. The Oliver,
Grover, and Lee paper raises significant questions about
what is driving Medicare GME costs. It does so even
though aggregating GME expenditures within states may
obscure some of the characteristics or practices of individ-
ual hospitals that result in very different GME payment
amounts. For example, for DGME, the hospital’s number
of residents, Medicare inpatient days, and accounting
practices at the start of PPS (when the level of cost per
resident was established as a basis for DGME costs) are
the primary determinants of payment. For IME, a specific
hospital’s number of residents, staffed beds, area wage
index, urban or rural location, and Medicare inpatient
utilization rate are the major determinants.
Declines in the IME Factor
When Congress passed the Social Security Amend-
ments of 1983 mandating a DRG-based PPS for Medi-
care inpatient services, it included report language
calling the IME “a proxy to account for a number of
factors that may legitimately increase costs in teaching
hospitals.” (For instance, an often-cited factor is a
teaching hospital’s having a more severely ill patient
caseload than is accounted for in its case-mix index.)
Because the IME is not an implicit educational pay-
ment, some have advocated giving it a strict definition.
For example, COGME, in its Fifteenth Report, proposes
that “IME payments should be set at no more than the
analytically justified level for teaching activities.”13
Beginning with hospitals’ 1984 fiscal year, the first
year of PPS, IME was an 11.59 percent add-on to each
DRG rate (for a Medicare patient) for every 10 percent
increase in a teaching hospital’s intern/resident-to-bed
(IRB) ratio. Subsequent omnibus reconciliation mea-
sures amended the IME factor provision as follows:
 COBRA reduced the IME factor to 8.1 percent for
fiscal years (FYs) 1986 and 1987 and to 8.7 percent
in future years.
 The Omnibus Budget Reconciliation Act of 1987
(OBRA) reduced the IME factor to 7.7 percent,
beginning in FY 1989.
 The BBA reduced the IME factor to 6.5 percent for
FY 1999. It also provided for the factor to decline to
6.0 percent in FY 2000 and to 5.5 percent in FY 2001,
provisions amended by the BBRA (see next bullet).
 The BBRA set the IME factor at 6.25 percent for
every 10 percent increase above 0.10 in the IRB
ratio and delayed for one year decreasing the factor
to 5.5 percent—as provided in the BBA.
 BIPA further delayed the BBA reductions in the
IME reduction, thereby restoring the IME factor to
6.5 percent until FY 2003, when it is slated to
decline to 5.5 percent.
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Table 1
Medicare GME Payments per Resident and Discharge




















UC Davis $29.76 $8,911 $37,129 $5,408 24% 410 4,828
Cedars-Sinai $30.80 $21,316 $49,572 $2,091 43% 228 12,404
UC San Francisco $34.08 $10,179 $46,268 $7,060 22% 529 4,064
Stanford University $43.28 $20,617 $64,428 $5,801 32% 323 6,312
UC Los Angeles $43.85 $11,169 $38,514 $5,150 29% 574 7,269
FLORIDA  
Orlando Regional HCS $9.53 $20,221 $67,403 $687 30% 123 10,253
Tampa General Hospital $10.90 $9,806 $33,814 $1,656 29% 196 5,422
Mount Sinai Medical Ctr $14.04 $29,672 $60,555 $1,313 49% 145 7,414
Jackson Memorial $18.49 $6,904 $57,533 $2,998 12% 614 4,753
Shands Teaching Hospital $26.56 $19,217 $73,912 $4,077 26% 380 4,723
MASSACHUSETTS  
Baystate Medical Center $30.26 $36,814 $102,261 $2,472 36% 237 8,710
U. Mass. Medical Center $35.14 $16,826 $42,065 $5,937 40% 304 5,057
Brigham & Women’s Hosp $37.07 $14,900 $62,083 $4,220 24% 456 7,173
Beth Israel Hospital $39.68 $32,879 $91,331 $3,674 36% 301 8,105
Mass. General Hospital $63.23 $30,325 $67,389 $3,636 45% 503 13,196
NEW YORK  
Long Island Jewish $49.63 $33,203 $92,231 $4,298 36% 476 7,869
Beth Israel Hospital $63.40 $66,250 $165,625 $2,074 40% 442 16,452
Presbyterian-Columbia $63.78 $21,395 $62,926 $4,358 34% 655 11,420
Mount Sinai Hospital $67.71 $41,752 $119,291 $3,881 35% 538 11,660
Montefiore Medical Ctr $95.00 $50,342 $122,785 $3,882 41% 770 14,485
PENNSYLVANIA  
Allegheny General Hosp $30.53 $26,868 $62,484 $2,391 43% 241 10,060
Albert Einstein Med Ctr $31.72 $48,604 $118,546 $3,089 41% 250 6,334
Thomas Jefferson $48.16 $29,243 $79,035 $3,837 37% 485 8,853
Univ. of Pennsylvania $57.68 $31,407 $95,173 $5,326 33% 521 7,758
UPMC Presbyterian $59.05 $34,957 $74,377 $3,931 47% 396 11,498
TEXAS  
Baylor University $17.84 $29,110 $78,676 $1,100 37% 148 12,302
Univ. of Texas (Houston) $19.38 $10,926 $57,505 $2,780 19% 474 5,109
Hermann Hospital $20.60 $7,135 $33,976 $4,074 21% 383 4,387
Scott and White Memorial $25.79 $65,318 $138,974 $2,056 47% 143 8,000
Methodist Hospital $27.20 $20,839 $42,529 $1,959 49% 196 11,797
* The adjusted rate (DME per resident/Medicare share of inpatient days) reflects the amount a hospital would have received if it
treated only Medicare patients.
Source: HCFA data as presented in “Variations in Medicare Payments for GME in California and Other States.”
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Table 2, prepared by the Division of Health Care
Affairs of the Association of American Medical Col-
leges (AAMC), charts the IME percentage add-on to
the DRG payment for illustrative intern-and-resident-to-
bed ratios incorporating changes mandated by the BBA,
BBRA, and BIPA.
STATE MEDICAID POLICIES
Even before the creation of the Medicaid pro-
gram—going back to just after World War II—most
states spent some of their budgets on medical education,
mainly for undergraduate training. With the inception of
Medicaid in all states except Arizona (which started its
program in 1982), states started contributing the second
largest amount of explicit GME funding.
A Profile of the States
Tim Henderson, program manager and director of
the Center for Primary Care and Workforce Analysis,
National Conference of State Legislatures (NCSL), has
done many of the analyses of Medicaid GME financing
that are available to policymakers. According to a study
that Henderson conducted for NCSL in 1998 and 1999
and reported in Health Affairs,
 A total of 45 states and the District of Columbia
paid for GME at some level.
 Of the 45 states and the District of Columbia, 43
paid for GME in their fee-for-service (FFS) pro-
grams. Of these, 24 made both IME and DGME
payments and 11 did not distinguish between the
two. Thirty-five of the states that paid for GME
under FFS did so through hospital per-case or per-
diem rates.
 Of the 42 states and the District of Columbia that
reported capitated Medicaid arrangements, 16 states
and the District of Columbia made explicit Medicaid
GME payments to teaching hospitals or teaching
programs. Seventeen other states included the pay-
ments in managed care organizations’ capitated rates.
Teaching hospitals were the recipients of most states’
GME payments, although, in Oklahoma and Tennes-
see, medical schools were the only training programs
to receive them directly under managed care.
 While medical residents were predominantly eligible
for Medicaid GME payments, nurses and other
health professions students were eligible under
managed care (or there was no distinction among the
health professions) in eight states and the District of
Columbia.
 Of the five states (and Puerto Rico) that did not
provide Medicaid GME support, only Illinois and
Puerto Rico had significant residency programs.
Alaska, Idaho, and Montana, which belonged to the
Washington-Wyoming-Alaska-Montana-Idaho
undergraduate and graduate medical education
program centered at the University of Washington,
did not have academic health centers. South Dakota
had one but did not report any GME payments to its
teaching hospital or medical school.14
Examples of Innovation
Some states have experimented with GME funds in
order to achieve certain goals. At an April 2001 state
health officials forum held by NCSL under the sponsor-
ship of HRSA,15 states that have taken the initiative in
Medicaid GME reported on their progress:
 Since 1997, Michigan has had three pools: one that
pays teaching hospitals at 1995 levels, one that
rewards them for their proportions of primary care
residents and indigent patients, and one for “innova-
tions” that gives grants to GME consortia made up
of a university, a hospital, and a health maintenance
organization (HMO). On July 1, 2001, the state
plans to implement a new formula for both the
historical (1995 base) and primary care pools. The
new formula will pay hospitals based on the number
of full-time employees in training. It will be weight-
ed both for Medicaid utilization and for performance
factors (that physicians participate in Michigan’s
Medicaid program after completing their residency
and that they receive board certification).16
 Also since 1997, Minnesota has operated a Medical
Education and Research Cost Fund—called
“MERC”—for clinical training costs. It is currently
funded by general revenues; the state’s tobacco
settlement; and federal Medicaid matching funds,
which are clearly earmarked for medical education. It
supports the unrecovered costs of clinical training for
medical students and residents, dental students and
residents, pharmacists, chiropractors, advanced
practice nurses, and physician assistants. It targets its
funds to cover a specific percentage of clinical training
costs at sites that provide care to the Medicaid popula-
tion. As part of MERC, the state instituted a managed
Medicaid carveout pool that became effective in 2000
but has yet to be extended to the entire state.17
 New York has a GME Reform Incentive Pool that has
the following goals: to reduce the number of physician





























































































































































































































































































































































































































































































































































































































































physicians, and to promote residency training in
ambulatory sites. Distribution of the funds, which
may be to individual hospitals or a consortium of
hospitals, is based on performance in meeting the
goals (for example, number of residents, primary-
care training, and number of ambulatory-care
sites).18
 Tennessee eliminated Medicaid GME funding in
January 1995, when it adopted TennCare, its Medic-
aid managed care program. After a study group had
evaluated TennCare’s role in funding GME and
developed a methodology, the state restored its
GME funding in 1996, retroactive to July 1995.
Under the new model (subject to a five-year phase-
in), the goals are to increase the training of Tenn-
Care physicians, retain them in underserved areas,
and direct GME money to nonhospital settings.
Payments go to medical schools, of which there are
four in the state, rather than to teaching hospitals.
Each medical school has its own primary care target
and is subject to a cutback in funding if it fails to
meet it. There is a set-aside for stipends to physi-
cians who stay in the state.19
 Texas has had discretionary programs to encourage
practice in rural areas and primary care training
since 1979. In addition to its graduate medical
residency program, it has family practice and pri-
mary care residency programs, plus a resident
physician compensation program, which supports
residency training in teaching hospitals. Its GME
program centers on eight medical schools and 11
independent primary care residencies. In terms of
Medicaid, the state opted in 1997 for a Medicaid
carveout of GME funds from HMO capitation rates
and directed the funds to teaching hospitals for
primary care residency training.20
 Based on a health professions education cost study
completed in 1996, Utah created the Medical Educa-
tion Council in 1997 to address the stabilization of
health professions education funding and to corre-
late the financing with workforce goals. The coun-
cil’s criteria include geographic balance, training
setting, encouragement of multidisciplinary educa-
tion, and stable funding for accredited programs.
The council would like to see both Medicaid and
Medicare funds paid to it. While the council has a
Medicare waiver application in its final stages with
the Health Care Financing Administration (HCFA),
it has made no progress on amending the state’s
Medicaid plan. Prior to last year, when the Utah
legislature approved $500,000 to stabilize a family
practice training program, the state had not provided
any funds for GME training.21
Adverse Effects of Managed Care and
the BBA
The growth of managed care in state Medicaid pro-
grams is assumed to have a negative effect on Medicaid
GME payments. From 1996 to 2000, the Medicaid
managed care population increased from 13.3 million to
18.8 million, or from 40.1 percent to 55.8 percent of the
total Medicaid population.22 Even if states pay managed
care organizations for GME, the organizations “are not
bound to distribute these dollars to hospitals with GME
programs or to provide GME themselves.”23
Moreover, the BBA may have had a chilling effect
on Medicaid GME because of a relationship between
Medicaid GME and Medicaid disproportionate-share
hospital (DSH) payments. The BBA reduced Medicaid
DSH payments by $10.4 billion over five years, a
reduction that was partly restored by the BBRA and
BIPA. Hospitals may have looked at Medicaid GME as
a trade-off for reduced Medicaid DSH payments, much
the same way in which they see a trade-off between the
Medicare DSH and IME adjustments.
AN EXAMINATION OF FEDERAL
REFORM PROPOSALS
Of the four major approaches to reforming Medicare
GME, tweaking the existing program seems to have
been the pathway of choice. However, the other three
have generated considerable discussion.
Minor Changes—
Tinkering around the Edges
Various changes have been made in the GME
program since it was initiated. According to Richard
Knapp, Ph.D., AAMC vice president,
six policy issues have dominated the Medicare DGME
debate since the enactment of COBRA: payments to
nonhospital entities, the duration of training for which
payment is made, the limitation of payments to certain
types or a defined number of residents, differential
payments by specialty, payments directly to programs,
and limits on the geographic variation in per-resident
payments.
In his view, only limits on geographic variation “have
been changed substantially.”24 The IME, as indicated,
has undergone significant downsizing: from 1983’s
11.59 percent to today’s 6.5 percent.
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A Major Change—
Folding DGME into IME
For the last two years, the Medicare Payment
Advisory Commission (MedPAC) has advocated
replacing the existing GME system with a new ap-
proach. In 1999, the commission proposed that DGME
and IME be combined into a single adjustment to DRG
rates, rather than having DGME be a pass-through
(albeit subject to restrictions) and having IME be an
adjustment to the DRG. It referred to the adjustment as
an “enhanced patient care” payment, a term that was
later dropped. It also advised revising certain aspects of
Medicare case-pricing, in order to achieve better
correlation between expected inpatient costs and actual
inpatient payments per case across various types of
hospitals.25
In its June 2000 Report to the Congress, the com-
mission reiterated its positions on what it now called “a
teaching adjustment” and on case-pricing. It provided
an analysis of its 1999 recommendations and con-
cluded:
The Congress should fold inpatient DGME costs into
PPS payment rates through a revised teaching hospital
adjustment. The new adjustment should be set such
that the subsidy provided to teaching hospitals contin-
ues as under current long-run policy. This recommen-
dation also should be implemented with a reasonable
transition to limit the impact on hospitals of substan-
tial changes in Medicare payments and to ensure that
beneficiaries have continued access to the services
that teaching hospitals provide.26
Joseph P. Newhouse and Gail R. Wilensky, two of
the MedPAC principals involved in the conception of
the commission’s proposal, justify merging DGME and
IME because they see “no economic reason for Medi-
care to distinguish” between them.
Both types of cost represent the additional cost of the
patient care provided at teaching hospitals. Thus, the
direct payments can be treated in the same fashion as
indirect costs. Doing so would resolve one anomaly of
the current payment method: direct GME costs are
reimbursed at the 1984 level of costs per resident,
trended forward by the change in the Consumer Price
Index. Reimbursement has been held at 1984 costs plus
inflation to preclude hospitals from simply moving
other costs to those that are now passed through. As
measured by Medicare, however, hospitals had very
different levels of costs per resident in 1984, in part
because some hospitals had more volunteer faculty (and
thus lower costs) and in part because of differences in
hospitals’ accounting practices in 1984.27
Entitlement to Authorization—
Taking the CHGME Model
Following the CHGME example of subjecting GME
costs to the authorization and appropriation process
would, of course, mean separating them from the
Medicare entitlement program. Not only would going
the authorization-appropriation route mean assigning
the significant GME dollars to different congressional
committees but it would also mean assigning the
program to a different administrative unit at the Depart-
ment of Health and Human Services (DHHS). The
House Ways and Means Committee and the Senate
Finance Committee now have Medicare GME in their
jurisdictions, as does HCFA at DHHS. CHGME falls
under the House Energy and Commerce Committee and
Appropriations Committee, as well as under the Senate
Health, Education, Labor, and Pension Committee and
Appropriations Committee. While DHHS’ HCFA has
Medicare GME, HRSA is in charge of CHGME.
While the National Bipartisan Commission on the
Future of Medicare did not come to a final vote on its
recommendations, one of its pending proposals was to
convert DGME to a program in which its funds would
be appropriated, while retaining IME as an HI Trust
Fund expenditure. Objections were raised that doing so
would make funding of DGME unpredictable and
capricious, forcing it to compete with other discretion-
ary health programs.
A Revenue Initiative—
Creating an All-Payer Fund
While the idea of an all-payer fund goes back to a
provision in former President Clinton’s Health Security
Act proposal, Sen. Daniel Patrick Moynihan (D-N.Y.),
who retired at the end of the 106th Congress, carried it
forward. Along with Rep. Nita M. Lowey (R-N.Y.), he
cosponsored the Medical Education Trust Fund Act of
1999, to establish separate Medicare and non-Medicare
trust funds for teaching hospitals and to create a medi-
cal school account. If enacted, the Moynihan-Lowey
approach would have levied a 1.5 percent tax on health
insurance premiums and administrative services as well
as drawn on 5 percent of federal Medicaid spending for
inpatient services to establish the non-Medicare ac-
count. Sen. Jack Reed (D-R.I.) has introduced the
legislation in the 107th Congress, joined by the two
Democratic senators of New York, Sens. Hillary
Rodham Clinton and Charles Schumer, as co-sponsors.
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The rationale for an all-payer fund is that “medical
education is a public good and that, because everyone
benefits from a well-trained workforce, everyone should
pay,” as Newhouse and Wilensky describe it. They
continue:
This notion is very different from economists’ view of
a public good. Loosely speaking, economists view a
good as being public if the benefits are equally avail-
able to everyone—that is, if consumers cannot be
excluded from consumption (for example, the light
from a lighthouse).28
According to COGME’s Fifteenth Report, the Pew
Health Professions Commission, Commonwealth Fund,
and associations representing major GME stakeholders
that signed a 1997 consensus agreement29 back some sort
of all-payer fund. However, given the lack of Republican
support to date for a new tax to mandate that private
insurers and health plans contribute to GME, the outlook
of such an initiative looks dim in the 107th Congress.
SOME KEY QUESTIONS
The meeting will raise and address various questions
about GME:
 How active should the federal and state govern-
ments be in influencing the health workforce? Why
should public insurance or general revenue funds be
used to fund the training of physicians and certain
other practitioners?
 To what extent does federal and state GME spend-
ing in the United States influence the numbers of
physicians (and perhaps other practitioners)? The
proportion of generalists to specialists? The propor-
tion of U.S. graduates to IMGs? The distribution of
practitioners in different geographic areas?
 What do variations in Medicare GME payments—
DGME and IME—mean in terms of the physician
workforce? The distribution of practitioners in
different areas?
 According to the report that accompanied the legisla-
tion that created the Medicare program, the program
should pay for GME “until the community under-
takes to bear such education costs in some other
way.” Does this statement have the same bearing that
it had in the mid-1960s? According to the report that
accompanied the legislation that established the
Medicare inpatient PPS program, IME is “a proxy to
account for a number of factors that may legitimately
increase costs in teaching hospitals.” What bearing
does this statement have today?
 Given changes in health service delivery and
financing—especially the shift from inpatient to
outpatient services—should teaching hospitals still
be the major recipients of GME funds? Is the HI
Trust Fund still the appropriate payer of GME costs?
 If GME were moved to ambulatory settings, what
would be the best way of structuring it?
 Would the federal authorization and appropriation
process be a more accountable way of funding
Medicare GME than the Medicare entitlement?
 What lessons do states that have experimented with
Medicaid GME have for federal policymakers
responsible for Medicare GME policy?
 Should states support Medicaid GME? Why or why
not? If so, at what financial level? How effective are
current Medicaid GME programs in helping states
meet their health professions workforce needs? How
flexible should DHHS be in permitting states to
experiment with Medicaid (and Medicare) GME
dollars?
 Does the political will exist to reform GME?
 Of the reform proposals on the table, which is the
most likely to gain consensus?
THE FORUM SESSION
This Forum session will look at the present strengths
and weakness of GME policy, at both the federal and
state levels, and proposals for reforming the federal
GME system. It will provide background on Medicare
GME spending in selected states. The meeting will also
feature discussion of Medicaid GME issues and the
impact of state policies both on state workforce con-
cerns and on federal GME reform.
Sheila P. Burke, Under Secretary for American
Museums and National Programs at the Smithsonian
Institution and a newly appointed member of MedPAC,
will moderate the meeting. She chairs NHPF’s Techni-
cal Advisory Group on Private Markets, which provides
guidance to the Forum on meeting and site visit pro-
grams. She has been at the Smithsonian for a year, after
having served as executive dean of the John F. Kennedy
School of Government, Harvard University, since 1997.
From 1986 to 1996, she was the chief of staff to then
Senate Majority Leader Robert Dole and was elected to
serve as secretary of the Senate in 1995. Earlier, she
was deputy staff director (1982 to 1985) and a profes-
sional staff member (1979 to 1982) of the Senate
Committee on Finance. Trained in nursing at the
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1. “GME is clinical training in an approved residency
program following graduation from schools of medicine,
osteopathy, dentistry, and podiatry. The training is required
for certification in a specialty and is approved by a non-
governmental accrediting organization for the specialty. The
residency program varies in length depending upon the
specialty.” Council on Graduate Medical Education
(COGME), Financing Graduate Medical Education in a
Changing Health Care Environment, Fifteenth Report,
December 2000, 1.
2. Traditionally known as direct medical education (DME)
costs, the term has evolved to DGME, in part due to the
former Prospective Payment Assessment Commission’s
(ProPAC’s) urging. DME more commonly refers to “durable
medical equipment.”
3. Tim M. Henderson, Funding of Graduate Medical
Education by State Medicaid Programs, a survey conducted
by the National Conference of State Legislatures (NCSL) for
the Association of American Medical Colleges (AAMC),
April 1999, 8.
4. Marilyn Biviano, “National Center for Health Workforce
Information and Analysis: Research Agenda,” slide presenta-
tion for the NCSL Forum for State Health Policy Leadership,
Lake Tahoe, California, April 26-27, 2001, 23.
5. American Medical Association, “Physician Characteristics
and Distribution in the U.S.,” Chicago, 15.
6. Cited by Richard Knapp, “Complexity and Uncertainty in
Financing Graduate Medical Education,” unpublished AAMC
paper based on a presentation made at the American Board of
Internal Medicine Summer Conference in Vail, Colorado,
August 2, 1999, 1.
7. Ralph W. Muller, “Making the Case for Public Support of
Teaching Hospitals and Medical Schools,” Academic Medi-
cine, 76, no. 2 (February 2001), 202-207.
8. COGME, Financing Graduate Medical Education, 17.
9. COGME, Financing Graduate Medical Education, 3.
10. ProPAC and the Physician Payment Review Commission
have since merged to form the Medicare Payment Advisory
Commission, or MedPAC.
baccalaureate level, she has an M.P.A. degree from
Harvard University.
Thomas R. Oliver, Ph.D., and Atul Grover, M.D.,
will describe the status of Medicare GME payments in
selected states. An associate professor of health policy
and management in the School of Hygiene and Public
Health at Johns Hopkins University, Oliver has pub-
lished extensively on health policy innovation and
system reform at the federal, state, and community
levels. He received an Investigator Award in Health
Policy Research from the Robert Wood Johnson
Foundation in 1993. He is a member of a study panel on
Medicare management and Governance convened by
the National Academy of Social Insurance. He received
his doctoral degree in political science from the Univer-
sity of North Carolina.
Grover is a post-doctoral National Research Service
Award fellow and Ph.D. candidate in health care policy in
the School of Hygiene and Public Health at Johns
Hopkins. A graduate of the George Washington Univer-
sity School of Medicine, where he was a National Health
Service Corps scholar, he completed residency training at
the University of California at San Francisco. He is a
board-certified specialist in internal medicine. His re-
search interests are medical education and primary care.
Edward S. Salsberg will review state Medicaid and
discretionary GME programs and their relationship to
state workforce goals. He is the director of the Center
for Health Workforce Studies, which he founded in
1996, and a faculty member at the School of Public
Health at the State University of New York at Albany.
Co-author of numerous reports and papers on the health
workforce, he is a member of the steering committee of
the National Academy for State Health Policy and of
the U.S. delegation to the International Physician
Workforce Conference. From 1984 to 1996, he was
bureau director at the New York State Department of
Health, where he specialized in health workforce and
primary care policies and programs. He has a master’s
degree in public administration from New York Univer-
sity’s Wagner School.
Barbara O. Wynn will comment on various factors
that affect GME payments, such as individual hospital
decisions regarding faculty costs, overhead expenses,
faculty practice plans, and volunteer and salaried
faculty. She will also address provisions in the BBRA
and BIPA that have narrowed the variation in DGME
payments and add her perspective on issues raised by
the other presenters. She has been a senior health policy
analyst at the RAND Corporation since 1999. Previ-
ously, she was with HCFA for 24 years. Her positions
included director of hospital payment policy, deputy
director and acting director of the Bureau of Policy
Development, and director of the Plan and Provider
Purchasing Policy Group. She guided the development
of regulatory policies implementing major provisions of
the Balanced Budget Act, including those affecting
payments for graduate medical education.
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